A cross-sectional cohort study of those with DRD with and without GCH1 mutations also found the GCH1 mutation-positive cohort to report lower rates of self-satisfaction and higher levels of major depressive episodes prior to prescription of L-Dopa [34]. This evidence concerns the gene GCH1 and dystonia 5.